Esperion Therapeutics, Inc. (ESPR)
2.855
+0.10
(+3.44%)
USD |
NASDAQ |
Mar 26, 15:29
Esperion Therapeutics Free Cash Flow : -13.09M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Nektar Therapeutics | -208.68M |
| Harrow, Inc. | 42.76M |
| Catalyst Pharmaceuticals, Inc. | 208.61M |
| Rigel Pharmaceuticals, Inc. | 75.66M |
| CytomX Therapeutics, Inc. | -75.81M |